Skip to main content

OnePlus 3 Nougat beta due this month, over-the-air update by end of 2016.

Image result for oneplus 3
Owners of the OnePlus 3 have some good news coming their way in the next few weeks. A new report confirms that OnePlus plans to release a “community” beta for the smartphone to support Android 7.0 Nougat sometime later this month, followed by an over-the-air Nougat update for all OnePlus 3 phones by the end of 2016.
The report comes from Engadget, who spoke to Brian Yoon, the head of software at OnePlus. He also confirmed that Nougat would be coming to some of its older smartphones like the OnePlus 2 at some point, but there’s no specific date for when that will happen. This news comes just a couple of months after the company decided to combine its HydrogenOS and OxygenOS development teams, in an effort to speed up the release of updates for its phones.
This news also comes just a few days before OnePlus reveals its next smartphone, which is rumored to have Nougat installed out of the box. The official reveal will be made on Tuesday, Nov. 15. In the meantime, are you excited that Nougat is going to be making its way to another smartphone in the near future?

Comments

Popular posts from this blog

The Secret Science 02:The 30 Most Disturbing Human Experiments in History

Disturbing human experiments aren’t something the average person thinks too much about. Rather, the progress achieved in the last 150 years of human history is an accomplishment we’re reminded of almost daily. Achievements made in fields like biomedicine and psychology mean that we no longer need to worry about things like deadly diseases or masturbation as a form of insanity. For better or worse, we have developed more effective ways to gather information, treat skin abnormalities, and even kill each other. But what we are not constantly reminded of are the human lives that have been damaged or lost in the name of this progress. The following is a list of the 30 most disturbing human experiments in history. 30. The Tearoom Sex Study Sociologist Laud Humphreys often wondered about the men who commit impersonal sexual acts with one another in public restrooms. He wondered why “tearoom sex” — fellatio in public restrooms — led to the majority of homosexual arrests in ...

The Strange and Stranger Case of Wyndham Lathem

A Northwestern University plague researcher has been charged with a brutal murder. Here’s what we know about him. WIKIMEDIA,  TONY WEBSTER O n July 27,  The  Chicago Tribune   reported that there was an arrest warrant issued for  Wyndham Lathem , a microbiologist at Northwestern University. The crime Lathem would later be charged with was brutal—26-year-old Trenton James Cornell-Duranleau, whose body was found in Lathem’s apartment, had been stabbed dozens of times. But Lathem was nowhere to be found. As events unfolded over the following days, it became clear he had fled from Chicago to California with a second suspect, 56-year-old Andrew Warren, a University of Oxford employee from the United Kingdom visiting the states. Along the way, the two men apparently made an anonymous $1,000 donation in Cornell-Duranleau’s name to the Lake Geneva Public Library and another donation for $5,610 to a Chicago health center. Lathem had also sent a video to fa...

Popular painkiller doesn’t have more heart risks than others, study claims

NEW ORLEANS — A long-awaited study on painkillers called nonsteroidal anti-inflammatory drugs, the most widely prescribed class of drugs in the world, has concluded that the three most commonly used carry a similar risk of cardiovascular complications. Yet critics say the study was too flawed to fairly compare them. Concerns about a type of NSAID called COX-2 inhibitors peaked in 2004 when the drug Vioxx was withdrawn from the market — a decision steeped in scandal because manufacturer Merck & Co had initially hidden data that would reveal the drug’s cardiovascular risks. A second COX-2 inhibitor, Pfizer Inc.’s Celebrex, was allowed to remain on the market with the condition that Pfizer conduct a study to prove that Celebrex was no worse than two older NSAIDs, naproxen and ibuprofen. The study lasted 10 years and enrolled more than 24,000 patients, but faced challenges. Doctors in European Union countries would not participate because they were worried a...